china

The drug safety scandals in recent weeks have underlined the risks to international consumers posed by weak oversight in China, the world’s largest supplier of active pharmaceutical ingredients. Chinese manufacturers account for 40 percent of the global production of such ingredients, according to the UK’s medicines regulator. It was an API was behind the first
0 Comments